Search results

Incarcerated transgender women often require healthcare to meet their physical-, mental-, and gender transition-related health needs; however, their healthcare experiences in prisons and jails and interactions with correctional healthcare providers are understudied. The paper aims to discuss these issues.

In 2015, 20 transgender women who had been incarcerated in the USA within the past five years participated in semi-structured interviews about their healthcare experiences while incarcerated.

Participants described an institutional culture in which their feminine identity was not recognized and the ways in which institutional policies acted as a form of structural stigma that created and reinforced the gender binary and restricted access to healthcare. While some participants attributed healthcare barriers to providers’ transgender bias, others attributed barriers to providers’ limited knowledge or inexperience caring for transgender patients. Whether due to institutional (e.g. sex-segregated prisons, biased culture) or interpersonal factors (e.g. biased or inexperienced providers), insufficient access to physical-, mental-, and gender transition-related healthcare negatively impacted participants’ health while incarcerated.

Findings highlight the need for interventions that target multi-level barriers to care in order to improve incarcerated transgender women’s access to quality, gender-affirmative healthcare.

This study provides first-hand accounts of how multi-level forces serve to reinforce the gender binary and negatively impact the health of incarcerated transgender women. Findings also describe incarcerated transgender women’s acts of resistance against institutional and interpersonal efforts to maintain the gender binary and present participant-derived recommendations to improve access to gender affirmative healthcare for incarcerated transgender women.

Teenagers are typically described as impulsive and risk taking. Yet recent research shows that this observation does not hold in all contexts. Rather, adolescents show higher impulsivity and risk taking than children or adults in affective contexts. Motivational and affective processes are therefore of particular interest when trying to understand typical adolescent behavior. Additionally, pubertal hormones are hypothesized to play a special role in adolescents’ motivated decision making. However, evidence for the mechanisms underlying this relationship is sparse. In this chapter, we aim to integrate findings from human and animal studies in order to elucidate the specific impact of pubertal hormones on motivational processes in adolescence. Against this background, we critically discuss and reinterpret recent findings in psychology and neuroscience, speculate about underlying mechanisms, and suggest new approaches for future studies of adolescent behavior.

The purpose of this paper is to present an artificial homeostatic system whose parameters are defined by means of an evolutionary process. The objective is to design a more biologically plausible system inspired by homeostatic regulations observed in nature, which is capable of exploring key issues in the context of robot behaviour adaptation and coordination.

The proposed system consists of an artificial endocrine system that coordinates two spatially unconstrained GasNet artificial neural network models, called non‐spatial GasNets. Both systems are dedicated to the definition of control actions in autonomous navigation tasks via the use of an artificial hormone and a hormone receptor. A series of experiments are performed in a real and simulated scenario in order to investigate the performance of the system and its robustness to novel environmental conditions and internal sensory disruptions.

The designed system shows to be robust enough to self‐adapt to a wider variety of disruptions and novel environments by making full use of its in‐built homeostatic mechanisms. The system is also successfully tested on a real robot, indicating the viability of the proposed method for coping with the reality gap, a well‐known issue for the evolutionary robotics community.

The proposed framework is inspired by the homeostatic regulations and gaseous neuro‐modulation that are intrinsic to the human body. The incorporation of an artificial hormone receptor stands for the novelty of this paper. This hormone receptor proves to be vital to control the network's response to the signalling promoted by the presence of the artificial hormone. It is envisaged that the proposed framework is a step forward in the design of a generic model for coordinating many and more complex behaviours in simulated and real robots, employing multiple hormones and potentially coping with further severe disruptions.

Traumatic brain injuries (TBIs) are a significant public health problem that affect an estimated 1.7 million US residents yearly. TBI patients experience a variety of symptoms related to physical functioning, sensory processing, cognition, communication, behavior, and mental health, all of which differ in severity by individual. Recent evidence suggests that hypothalamic pituitary dysfunction may be impacting recovery. The purpose of this paper is to increase awareness about the frequency of hypothalamic pituitary dysfunction following a TBI and its effect on functional recovery.

The paper reviews the literature regarding hypothalamic pituitary dysfunction following TBI and discusses the potential benefits of hormone replacement therapy for individuals with hormone deficiencies.

The rate of hypothalamic pituitary dysfunction following TBI has been reported as anywhere between 25 and 80 percent. Specifically, abnormal hormone levels, both chronic and acute, are generally estimated to be approximately 5-22 percent for thyroid hormones, 15-33 percent for growth hormone (GH), and 25-80 percent for testosterone. The effect of hypopituitarism has been reported on several aspects cognitive and physical function as well as overall quality of life. In these studies, GH and testosterone deficiencies appear to underlie the observed impairments.

The paper suggests the importance of understanding and screening for hypothalamic pituitary dysfunction as hormone replacement therapy may be a beneficial intervention to promote physical and cognitive rehabilitation.

This article focuses on the assessment of thyroid hormones in 64 pregnant women in Mauritius. Our study revealed that serum thyroid‐stimulating hormone was significantly raised in four pregnant women with normal serum‐free tri‐iodothyronine and serum‐free thyroxine. It was also noted that mean serum‐free tri‐iodothyronine was non‐significantly much lower in the pregnant women. It is concluded that the four pregnant women with an abnormally elevated serum thyroid‐stimulating hormone together with normal free thyroid hormones probably have subclinical hypothyroidism.

In a full blaze of comings and goings, it is unnecessary to remind ourselves that the holiday season is upon us; mass travel to faraway places. The media have for months, all through the winter, been extolling a surfeit of romantic areas of the world, exspecially on television; of colourful scenes, exotic beauties, brilliant sunshine everywhere; travel mostly by air as so‐called package tours — holidays for the masses! The most popular areas are countries of the Mediterranean littoral, from Israel to Spain, North Africa, the Adriatic, but of recent years, much farhter afield, India, South‐east Asia and increasingly to the USA.

Agricultural trade has generated more than its share of disputes in the past fifty years. Lack of a clear structure of rules to constrain government activity in these markets, coupled with the particularly sensitive nature of trade in basic foodstuffs, has been the main cause of this disproportion. New rules agreed in the Uruguay Round provided an improved framework for government policy in this area, and a temporary exemption was given to certain subsidies from challenge in the WTO (the Peace Clause). However, the expiry of the Peace Clause in 2003 and a growing willingness on the part of exporters to challenge domestic farm programs in other countries through action under the Dispute Settlement Understanding has once again stirred the agricultural pot. Now trade disputes are frequently leading to litigation, encouraged by the slow progress in the Doha Round of trade negotiations. In particular, the scope for domestic subsidies, under the Agreement on Agriculture and the Agreement on Subsidies and Countervailing Measures, has increasingly become the subject of litigation. Countries may have to further modify their domestic policies so as to reduce their vulnerability to challenge in the WTO.

This study aims to estimate the prevalence of individuals receiving hormone therapy for menopause management and the prevalence of underlying conditions that may constrain options for pharmacologic menopause management in the prison context.

This study reviewed all prescriptions dispensed by the North Carolina Department of Public Safety between July 1, 2015, and June 30, 2016, for relevance to menopause management. Relevant medications were those either recommended for menopause management or those indicated for management of conditions that may complicate menopause management, as per the 2015 clinical decision-support algorithm tool developed by the North American Menopause Society. Analysis was restricted to women between the ages of 45 and 75.

Of 1,120 women, a majority (77.8%) were between the ages of 45 and 54. Less than 5% of individuals in this study were prescribed estrogen-containing therapy. The most commonly prescribed medications that may constrain options for menopause treatment were related to hypertension and other cardiovascular disease or mental health conditions.

The retrospective nature of this data set limits the findings, given that researchers did not have access to diagnoses or data on polypharmacy. Still, this study indicates that many women over 45 experiencing incarceration are living with health conditions that may complicate menopause symptom management with hormone therapy. Future research in carceral settings must examine the prevalence of menopause-related symptoms as well as access to and quality of comprehensive menopause management.

There is a paucity of literature around the menopause-related needs of individuals experiencing incarceration. To the best of the authors’ knowledge, no other research has examined prevalence of pharmacologic menopause management among women who are incarcerated.

Selenium is an essential trace element for both men and animals at lower concentrations and has toxic effects at higher concentrations. The element’s essentiality was first recognised in 1957. Low bioavailability could be contributing to cancers, cardiovascular disease, and subfertility. Selenium and its compounds are widely used in stainless steel production, as a pigment in ceramics, vulcanizing agent of rubber, lubricants, fungicides, medicines used in dermatology and in radionulide imaging of the pancreas. Selenium’s annual world production is estimated at 1,350 tonnes. In the last decade selenium was shown to be an essential component of type I oidothyronine 5’ deiodinase which converts tyroxin to the more biologically active hormone 3,5,3’‐triiodothyronine. The function of selenium in thyroid hormone metabolism has important implications for the interpretation of the effects of selenium deficiency, especially in an elderly population. The population of the elderly has grown in numbers during recent years, throughout the world. The thyroid gland function in a great measure defines the quality of life in elderly people. The purpose of this review is to show the role of selenium in thyroid hormone metabolism.